Coastwise Capital Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.93M Buy
80,028
+4,074
+5% +$107K 1.12% 17
2026
Q1
$2.13M Buy
75,954
+23
+0% +$612 1.18% 16
2025
Q4
$1.89M Sell
75,931
-1,657
-2% -$41.8K 0.94% 20
2025
Q3
$1.98M Buy
77,588
+2,364
+3% +$58.3K 1.39% 16
2025
Q2
$1.82M Buy
75,224
+633
+0.8% +$14.8K 1.45% 15
2025
Q1
$1.89M Buy
74,591
+1,856
+3% +$48.6K 1.59% 13
2024
Q4
$1.93M Buy
72,735
+5,172
+8% +$140K 1.54% 13
2024
Q3
$1.96M Sell
67,563
-4,353
-6% -$127K 1.61% 13
2024
Q2
$2.01M Buy
71,916
+4,529
+7% +$125K 1.92% 11
2024
Q1
$1.87M Buy
67,387
+31,920
+90% +$886K 1.73% 11
2023
Q4
$1.02M Buy
35,467
+1,930
+6% +$58.3K 1.04% 27
2023
Q3
$1.11M Buy
33,537
+6,296
+23% +$223K 1.27% 20
2023
Q2
$999K Buy
27,241
+4,916
+22% +$191K 1.13% 23
2023
Q1
$911K Buy
22,325
+11,091
+99% +$479K 1.04% 28
2022
Q4
$576K Buy
11,234
+2,398
+27% +$115K 0.68% 37
2022
Q3
$387K Sell
8,836
-648
-7% -$31.5K 0.61% 52
2022
Q2
$497K Buy
9,484
+1,134
+14% +$57.8K 0.61% 50
2022
Q1
$432K Buy
+8,350
New +$433K 0.54% 59

Other funds holding PFE

Coastwise Capital Group's PFE Position: Q2 2026 in Review

Coastwise Capital Group increased its Pfizer (PFE) stake by 5.4% in Q2 2026, buying an estimated $107K and bringing the position to 80,028 shares worth $1.93M. The position accounts for 1.12% of the portfolio, ranked #17.

Coastwise Capital Group first reported a position in PFE in Q1 2022 and has held it in 18 quarters since. The position peaked at $2.13M in Q1 2026. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Coastwise Capital Group held 80,028 shares of Pfizer worth $1.93M as of Q2 2026.
  • Coastwise Capital Group bought 4,074 Pfizer shares in Q2 2026, an estimated $107K.
  • Pfizer made up 1.12% of Coastwise Capital Group's portfolio in Q2 2026, its #17 holding.
  • Coastwise Capital Group first reported a position in Pfizer in Q1 2022 and has held it in 18 quarters since.
  • Coastwise Capital Group's Pfizer position peaked at $2.13M in Q1 2026.
  • 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Coastwise Capital Group's 13F filing for Q2 2026, filed 16 Jul 2026.